AIM ImmunoTech Analyst Price Targets

Wall Street analyst price targets and consensus rating for AIM ImmunoTech (AIM).

Price Target Range — 5 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$4Upside to Avg. PT+2122.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 20, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$9→$7
Jun 1, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$10→$9
Apr 10, 2026	Ascendiant Capital	Edward Woo	PT Cut	Buy	$22→$10
Dec 8, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$24→$22
Oct 3, 2025	Ascendiant Capital	Edward Woo	PT Cut	Buy	$150→$24
Dec 10, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$5→$5
Oct 22, 2024	Maxim Group	Jason McCarthy	PT Cut	Buy	$2→$1
Sep 3, 2024	Ascendiant Capital	Edward Woo	PT Cut	Buy	$5→$5

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $7

Ascendiant Capital analyst Edward Woo maintains AIM ImmunoTech (AMEX:AIM) with a Buy and lowers the price target from $9 to $7.

Benzinga Newsdesk

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $9

Ascendiant Capital analyst Edward Woo maintains AIM ImmunoTech (AMEX:AIM) with a Buy and lowers the price target from $10 to $9.

Benzinga Newsdesk

Constellation Brands To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday

Top analysts changed outlook on top names. For complete view of all rating changes, see analyst ratings page. See others' views on stocks.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $10

Ascendiant Capital analyst Edward Woo maintains AIM ImmunoTech (AMEX:AIM) with a Buy and lowers the price target from $22 to $10.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $22

Ascendiant Capital analyst Edward Woo maintains AIM ImmunoTech (AMEX:AIM) with a Buy and lowers the price target from $24 to $22.

Benzinga Newsdesk

AIM ImmunoTech Inc

AIM ImmunoTech Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $7

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $9

Constellation Brands To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $10

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $22

People Also Watch

People Also Watch

AIM ImmunoTech Inc

AIM ImmunoTech Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROAscendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $7

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

PROAscendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $9

Constellation Brands To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday

PROAscendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $10

PROAscendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $22

People Also Watch

People Also Watch

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $7

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $9

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $10

PRO
Ascendiant Capital Maintains Buy on AIM ImmunoTech, Lowers Price Target to $22